Phillip Lieberman

Summary

Affiliation: University of Tennessee
Country: USA

Publications

  1. ncbi request reprint Biphasic anaphylactic reactions
    Phil Lieberman
    Department of Medicine and Pediatrics, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 95:217-26; quiz 226, 258. 2005
  2. ncbi request reprint Nonallergic rhinitis
    Phil Lieberman
    Clinical Professor of Medicine and Pediatrics, University of Tennessee College of Medicine, Allergy and Asthma Care, 7205 Wolf River Blvd, Suite 200, Germantown, TN, 38138, USA
    Curr Allergy Asthma Rep 14:439. 2014
  3. doi request reprint Histamine, antihistamines, and the central nervous system
    Philip Lieberman
    Departments of Medicine and Pediatrics, University of Tennessee, Memphis, Tennessee, USA
    Allergy Asthma Proc 30:482-6. 2009
  4. doi request reprint Intranasal antihistamines for allergic rhinitis: mechanism of action
    Philip Lieberman
    Division of Allergy and Immunology, University of Tennessee, 7205 Wolf River Boulevard, Suite 200, Germantown, TN 38138, USA
    Allergy Asthma Proc 30:345-8. 2009
  5. doi request reprint Epidemiology of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, Tennessee, USA
    Curr Opin Allergy Clin Immunol 8:316-20. 2008
  6. ncbi request reprint Objective measures of asthma control: sputum eosinophils, nitric oxide, and other inflammatory mediators
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, TN, USA
    Allergy Asthma Proc 28:510-3. 2007
  7. ncbi request reprint The unusual suspects: a surprise regarding reactions to omalizumab
    Phil Lieberman
    Division of Allergy and Immunology, University of Tennessee, Memphis, Tennessee, USA
    Allergy Asthma Proc 28:259-61. 2007
  8. ncbi request reprint SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department
    Philip Lieberman
    Division of Allergy and Immunology, Department of Internal Medicine and Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee, USA
    Ann Allergy Asthma Immunol 98:519-23. 2007
  9. ncbi request reprint Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
    Phil Lieberman
    Division of Allergy Immunology, Department of Medicine, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:596-602. 2006
  10. ncbi request reprint Anaphylaxis
    Phillip Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee College of Medicine, Memphis, TN 38138, USA
    Med Clin North Am 90:77-95, viii. 2006

Detail Information

Publications20

  1. ncbi request reprint Biphasic anaphylactic reactions
    Phil Lieberman
    Department of Medicine and Pediatrics, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 95:217-26; quiz 226, 258. 2005
    ..To examine the impact of the second phase of a biphasic response on the required observation time after resolution of symptoms that occurred during the initial phase...
  2. ncbi request reprint Nonallergic rhinitis
    Phil Lieberman
    Clinical Professor of Medicine and Pediatrics, University of Tennessee College of Medicine, Allergy and Asthma Care, 7205 Wolf River Blvd, Suite 200, Germantown, TN, 38138, USA
    Curr Allergy Asthma Rep 14:439. 2014
    ..This review will concentrate on chronic nonallergic rhinitis in its various forms, discussing the epidemiology, underlying mechanisms, and its therapy. ..
  3. doi request reprint Histamine, antihistamines, and the central nervous system
    Philip Lieberman
    Departments of Medicine and Pediatrics, University of Tennessee, Memphis, Tennessee, USA
    Allergy Asthma Proc 30:482-6. 2009
    ..Second-generation antihistamines have been designed to minimize blood-brain barrier penetration by reducing lipophilicity and increasing the affinity for P-aminnoglycoprotein...
  4. doi request reprint Intranasal antihistamines for allergic rhinitis: mechanism of action
    Philip Lieberman
    Division of Allergy and Immunology, University of Tennessee, 7205 Wolf River Boulevard, Suite 200, Germantown, TN 38138, USA
    Allergy Asthma Proc 30:345-8. 2009
    ....
  5. doi request reprint Epidemiology of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, Tennessee, USA
    Curr Opin Allergy Clin Immunol 8:316-20. 2008
    ..This, in turn, has a bearing on efforts related to prevention and management...
  6. ncbi request reprint Objective measures of asthma control: sputum eosinophils, nitric oxide, and other inflammatory mediators
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, TN, USA
    Allergy Asthma Proc 28:510-3. 2007
    ..Therefore, tools to measure the status of inflammation would be extremely helpful. In this article two such tools are discussed: the measurement of eosinophilia and the assessment of exhaled nitric oxide...
  7. ncbi request reprint The unusual suspects: a surprise regarding reactions to omalizumab
    Phil Lieberman
    Division of Allergy and Immunology, University of Tennessee, Memphis, Tennessee, USA
    Allergy Asthma Proc 28:259-61. 2007
  8. ncbi request reprint SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department
    Philip Lieberman
    Division of Allergy and Immunology, Department of Internal Medicine and Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee, USA
    Ann Allergy Asthma Immunol 98:519-23. 2007
    ....
  9. ncbi request reprint Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
    Phil Lieberman
    Division of Allergy Immunology, Department of Medicine, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:596-602. 2006
    ..To improve understanding of the epidemiology of anaphylaxis...
  10. ncbi request reprint Anaphylaxis
    Phillip Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee College of Medicine, Memphis, TN 38138, USA
    Med Clin North Am 90:77-95, viii. 2006
    ..Any patient predisposed to anaphylactic episodes should wear identifying medical jewelry and avoid, whenever possible, drugs that could worsen an event or complicate its therapy...
  11. ncbi request reprint Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis
    Phil Lieberman
    Allergy and Asthma Care, Germantown, TN, USA
    Curr Med Res Opin 21:611-8. 2005
    ....
  12. doi request reprint Vasomotor rhinitis
    Debendra Pattanaik
    Allergy and Asthma Care, 7205 Wolf River Boulevard, Suite 200, Germantown, TN 38138, USA
    Curr Allergy Asthma Rep 10:84-91. 2010
    ..However, in patients whose predominant symptom is rhinorrhea, use of atopical anticholinergic agents can be quite useful. Up-to-date pathogenesis, epidemiology, diagnosis, and treatment approaches are discussed in this review...
  13. ncbi request reprint Anaphylaxis: a review of 601 cases
    Luke M Webb
    Department of Internal Medicine, University of Tennessee, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:39-43. 2006
    ..Knowledge of the characteristics of such patients is essential to achieve these goals...
  14. ncbi request reprint The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen
    Mathew Varghese
    University of Tennessee, Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA
    Allergy Asthma Proc 28:320-3. 2007
    ..Furthermore, a positive skin test to mouse antigen does not automatically preclude the use of omalizumab for therapy of moderate-to-severe allergic asthma...
  15. ncbi request reprint Use of epinephrine in the treatment of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, Memphis, Cordova, Tennessee 38018, USA
    Curr Opin Allergy Clin Immunol 3:313-8. 2003
    ..This paper is intended to review recent literature that impacts the use of epinephrine in the therapy of anaphylaxis...
  16. ncbi request reprint Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations
    John W Tole
    Department of Internal Medicine, University of Tennessee Health Science Center, 842 Jefferson Avenue, Suite A601, Memphis, TN 38103, USA
    Immunol Allergy Clin North Am 27:309-26, viii. 2007
    ....
  17. ncbi request reprint Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology
    Leonard Bielory
    Department of Medicine, UMDNJ New Jersey Medical School, Newark, USA
    Ann Allergy Asthma Immunol 96:514-25. 2006
    ..Thus, as stated, we recommend that intranasal corticosteroids remain prescription-only drugs...
  18. ncbi request reprint Anaphylactic reactions during surgical and medical procedures
    Phil Lieberman
    Division of Allergy and Immunology, Departments of Medicine and Pediatrics, University of Tennessee, Memphis, TN 38018, USA
    J Allergy Clin Immunol 110:S64-9. 2002
    ..This is particularly important in the operating and recovery rooms...
  19. ncbi request reprint Translating science to community action
    Phillip Lieberman
    Ann Allergy Asthma Immunol 96:381-2. 2006